• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study.

广告
第一作者: Maciej,Banach
第一单位: Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.
作者单位: Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland. [1] Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. [2] Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland. [3] Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States. [4] Sanofi, Bridgewater, NJ, United States. [5] Department of Population Health Monitoring and Analysis, National Institute of Public Health NIH-National Research Institute, Warsaw, Poland. [6] Department of Cardiology, Elias Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. [7] The 3rd Department of Internal Medicine-Metabolic Care and Gerontology, Charles University and University Hospital in Hradec Králové, Hradec Králové, Czechia. [8] 3rd Department of Medicine-Department of Endocrinology and Metabolism of the First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia. [9] Department of Internal Medicine and Geriatric Cardiology, Center of Postgraduate Medical Education, Warsaw, Poland. [10] Department of Epidemiology and Health Promotion, School of Public Health, Center of Postgraduate Medical Education, Warsaw, Poland. [11] Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland. [12] Cardiometabolic Center, Metropolitan Hospital, Piraeus, Greece. [13] First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece. [14] Department of Medical Specialties I, "Grigore T. Popa", University of Medicine and Pharmacy, Iasi, Romania. [15] Cardiovascular Rehabilitation Clinic, Clinical Rehabilitation Hospital, Iasi, Romania. [16] University Clinical Center Maribor, Maribor, Slovenia. [17] Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. [18] Sanofi, Warsaw, Poland. [19] 2nd Department of Cardiology of the East Slovak Institute of Cardiovascular Disease and Faculty of Medicine, PJ Safarik University, Kosice, Slovakia. [20]
DOI 10.3389/fcvm.2023.1206551
PMID 37404744
发布时间 2023-07-18
提交
  • 浏览0

Frontiers in cardiovascular medicine

2023年10卷

1206551页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷